Kidney disease patients say cannabis helps manage overwhelming symptoms but face major barriers to accessing it legally | Research

The takeaway

A qualitative study found that kidney failure patients used cannabis (mostly non-prescribed) to manage severe symptoms like pain and mental health burden, but faced financial barriers, stigma, and a lack of clinician support for prescribed options.

Kidney disease patients, nephrologists, medical cannabis policy advocates

13 of 17 kidney patients used non-prescribed cannabis due to access barriers

What the researchers found

Of 17 participants, 13 used non-prescribed and 4 used prescribed cannabis. Four themes emerged: using cannabinoids to relieve an overwhelming symptom burden; barriers to accessing medical cannabis including cost and stigma; weighing risks of unregulated products; and lack of clinician knowledge and support. Most had hemodialysis experience.

Why it matters

Kidney failure patients experience severe symptoms that are often poorly managed with existing treatments. This study gives voice to patients navigating a complex landscape where the treatments they find helpful are often inaccessible or stigmatized.

The numbers in context

17 participants (13 non-prescribed, 4 prescribed cannabis); most had hemodialysis experience; 4 main themes identified with subthemes

How the study worked

Qualitative semistructured interview study with patients who had used either prescribed or non-prescribed cannabis to manage kidney failure symptoms. Data were coded inductively to identify themes and a conceptual framework.

What this study cannot tell us

Small sample (17 participants) limits generalizability. Self-selected participants likely to have positive views of cannabis. No objective symptom measurement. Qualitative design does not establish efficacy.

How to read the evidence

Preliminary: small qualitative study providing patient perspectives without measuring clinical outcomes or controlling for confounders.

When this study was published

2026 publication from a qualitative study of kidney disease patients.

The bigger picture

This reflects a broader pattern across chronic disease populations: patients turning to cannabis for symptom relief but finding formal medical channels unresponsive or inaccessible. The disconnect between patient experience and clinical practice persists.

Questions still open

Could cannabis interact with dialysis medications? What specific kidney disease symptoms respond best to cannabis? Would nephrologist education about medical cannabis change prescribing patterns?

Common questions

Why do kidney disease patients use cannabis?

Patients described using it to manage overwhelming symptoms including pain, mental health burden, and other issues poorly addressed by available treatments. Many felt abandoned managing their symptom burden.

Why do most use non-prescribed cannabis?

Barriers to prescribed cannabis included high cost, legal restrictions, and clinicians who lack knowledge about prescribed options. This pushed patients toward unregulated products despite safety concerns.

Read the original research

Patients' Perspectives and Experiences of Cannabinoids to Manage Symptoms of Chronic Kidney Disease: An In-Depth Interview Study.

Hemodialysis international. International Symposium on Home Hemodialysis, 30(1), 149-157

View on PubMed ↗Publisher’s paper ↗

Citation

Walker, Rachael C; Jackson, Angela; Semple, David; Green, Suetonia C. (2026). Patients' Perspectives and Experiences of Cannabinoids to Manage Symptoms of Chronic Kidney Disease: An In-Depth Interview Study.. Hemodialysis international. International Symposium on Home Hemodialysis, 30(1), 149-157. https://doi.org/10.1111/hdi.70038